The brain metabolic disorder is defined as follows. - Metabolism is your process of using energy and behavior from the food you eat. Food consists of carbohydrates, proteins and fats. Chemical substances in the gastrointestinal tract destroy food fragments contained in stomach acid and sugar and give energy to the body. You can use your body fuel soon, or it can store energy in body tissues such as the liver, muscle and fat in the body. Metabolic disorders are present in mothers and infants and cause neurodevelopmental disorders.
Last week 's Cogs 163: Metabolic diseases and brains have focused on the intestinal flora and its impact on mind, body, and behavior. The focus of this week's blog is to review John F. Cryan and Timothy G. Dinan's research, "The changing heart of microorganisms: the influence of intestinal microflora on brain and behavior" (Nature Reviews, vol.13 , October 2012). . Their review reviewed and examined a series of evidences surrounding the concept of microbial - intestinal - brain axis. This microbiome - intestine - brain axis means the path of communication and influence that connects the unique composition of bacteria in each of our intestines to the central nervous system and brain.
They recently re-emerged in my current class Metabolic Disorders and Brain. And I will use this blog post to clarify how cool the classical conditioning is about metabolic disorders. ) Last week we talked about insulin, insulin is a hormone produced by the pancreas. I do not know you, but whenever I think about insulin, I did not think about it. Why should I? My idea turns into diabetes quickly How does insulin work in the body to treat extra sugar in the blood?
Insulin is important for glucose metabolism and is used for the treatment of diabetes, impaired glucose metabolism in the body. Initially insulin derived from animals was used to treat diseases, but synthetic human insulin is used for rapid absorption by the human body, reduction of allergic reactions, reduction of impurities, and better results ( 3). Synthetic insulin was originally produced by genetic engineering in 1983 and extraction of human DNA was done once extracted (1), the insulin gene was isolated and the enzyme was used to cleave it. The gene is then enzymatically cleaved and placed in the vector plasmid. In this case, in most cases E. coli plasmids are used. Since insulin contains two chains, two DNAs are extracted and the genes of the two chains are bound to the bacterial β-galactosidase. The resulting plasmid is then inserted into host cell E. coli and sealed with another enzyme called ligase.